Indivior Pharmaceuticals, Inc. (INDV)
34.79
+0.02
(+0.06%)
USD |
NASDAQ |
Oct 21, 16:00
34.89
+0.10
(+0.29%)
After-Hours: 20:00
Indivior Pharmaceuticals Net Income (Annual) : 210.00M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 210.00M |
| December 31, 2024 | 7.00M |
| December 31, 2023 | -129.00M |
| December 31, 2022 | -53.00M |
| December 31, 2021 | 205.00M |
| December 31, 2020 | -148.00M |
| December 31, 2019 | 134.00M |
| December 31, 2018 | 275.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 58.00M |
| December 31, 2016 | 35.00M |
| December 31, 2015 | 228.00M |
| December 31, 2014 | 403.00M |
| December 31, 2013 | 489.00M |
| December 31, 2012 | 607.00M |
| December 31, 2011 | 614.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Supernus Pharmaceuticals, Inc. | -38.55M |
| Eli Lilly & Co. | 20.64B |
| Bristol Myers Squibb Co. | 7.056B |
| Liquidia Corp. | -68.92M |
| Harmony Biosciences Holdings, Inc. | 158.69M |